3. Segment Information and Concentrations (Tables)

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Information

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2014
Revenues	$	4,679,100	$	1,923,300		$	190,800		$	—		$	6,793,200
Foreign Sales		2,617,300		866,900			2,000			—			3,486,200
Income (Loss) from Opertions		156,000		(145,700	)		(49,500	)		(79,500	)		(118,700	)
Assets		4,129,100		1,535,300			799,800			647,600			7,111,800
Long-Lived Asset Expenditures		1,476,500		11,300			8,500			—			1,496,300
Depreciation and Amortization		130,900		35,000			96,900			—			262,800
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2013
Revenues	$	4,466,000	$	2,541,500		$	127,000		$	—		$	7,134,500
Foreign Sales		2,549,100		1,603,800						—			4,152,900
Income (Loss) from Operations		525,900		151,400			(169,900	)		—			507,400
Assets		2,501,600		1,646,600			903,600			1,101,200			6,153,000
Long-Lived Asset Expenditures		18,300		23,300			9,200			—			50,800
Depreciation and Amortization		43,300		35,300			100,200			—			178,800